Olink

Olink®
Part of Thermo Fisher Scientific

Filters

PublicationDisease areaApplication areaSample typeProducts

Molecular Neurobiology, 2026
Comparative Analysis of Mouse CSF Proteins in Experimental Autoimmune Encephalomyelitis Model and Cuprizone-Induced Demyelination Model by Olink Proteomics

Bernaerts E., Rutten M., De Visscher A. et al.

Olink Target 96 MouseNeurologyPathophysiologyMouse Csf

GeroScience, 2026
Multiorgan transcriptomics and circulating extracellular vesicle profiling reveal age-dependent systemic vulnerability to isoflurane anesthesia and surgery

Krishnamachary B., Lee H., Wang Z. et al.

Olink Target 96 MouseAgingSurgical ComplicationsPathophysiologyMouse EV Lysate

RMD Open, 2026
Cardiovascular health and osteoarthritis risk: a prospective cohort study with proteomic insights from UK Biobank

Luo J., Chen X., Chen N. et al.

Olink Explore 3072/384Immunological & Inflammatory DiseasesCVDPathophysiologyPlasma

Briefings in Bioinformatics, 2026
StackAge: an ensemble-based clock for precise quantification of biological age using multi-omics data

Jiang Y., Jia L., Fei Y. et al.

Olink Explore 3072/384Wider Proteomics StudiesAgingPathophysiologyPlasma

Clinical and Translational Medicine, 2026
Investigations into the aetiopathogenesis of orofacial granulomatosis using multiple omics technologies reveal a potential role for B cells

Tumelty M., Patel K., Petersen H. et al.

Olink Target 96Immunological & Inflammatory DiseasesPathophysiologySaliva

Journal of Thrombosis and Haemostasis, 2026
Development of novel plasma proteomic biomarkers for cancer-associated thrombosis in an advanced cancer cohort

Preeti P., Ranjan M., Pham D. et al.

Olink Explore HTOncologyHematologyPatient StratificationPlasma

Cardiovascular Therapeutics, 2026
Genetic Evidence Linking Inflammatory Cytokines and Blood Metabolites to Heart Failure Risk

Yao Y., Tang L., Zhou P. et al.

Olink Target 96CVDPathophysiologyPlasma

European Journal of Endocrinology, 2026
Targeted Proteomics Reveals Novel Biomarkers of Disease Activity and Inflammation in Acromegaly

Godang K., Wessel M., Khan Y. et al.

Olink Target 96EndocrinologyPatient StratificationPlasma

Diabetes, Obesity and Metabolism, 2026
Large‐Scale Plasma Proteomics Improves Prediction of Major Adverse Liver Outcomes in Individuals With MASLD

Yu H., Huang Y., Wang J. et al.

Olink Explore 3072/384Metabolic DiseasesHepatologyPatient StratificationPlasma

Clinica Chimica Acta, 2026
Emerging biomarkers in IgA nephropathy, membranous nephropathy, and lupus nephritis

Kobayashi H., Murata Y., Akiya Y. et al.

Olink FocusImmunological & Inflammatory DiseasesNephrologyPathophysiologySerum

Journal of Extracellular Biology, 2026
Heparan Sulphate Glycosaminoglycan Chains Contribute to the Tethering of Coronal Factors and Are Important for Extracellular Vesicle‐Mediated Fibroblast Activation

Veiga S., Shephard A., Milward K. et al.

Olink Target 96Wider Proteomics StudiesPathophysiologyEV Lysate

Genes & Diseases, 2026
Identification of novel therapeutic targets for heart failure and its subtypes: Insights from proteomic and transcriptomic Mendelian randomization

Huang H., Ruan H., Liu J. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Nature Communications, 2026
Multi-omics integration predicts the incidence of 17 diseases in the UK Biobank

Du J., Zhou M., Wang H. et al.

Olink Explore 3072/384Wider Proteomics StudiesPatient StratificationPlasma

eBioMedicine, 2026
Influence of obesity on susceptibility to systemic symptoms and host responses to orthoflaviviral infection: a prospective observational study using yellow fever vaccine to simulate acute infection

Syenina A., Tham C., Tng D. et al.

Olink Target 48Metabolic DiseasesInfectious DiseasesPathophysiologyPlasma

Phytomedicine, 2026
Combination of andrographolide and baicalin inhibited influenza A virus infection through suppressing RORγt-IL-17A pathway

Cui Y., Yue Y., Lin H. et al.

Olink Target 96Infectious DiseasesPathophysiologyMouse Balf

npj Aging, 2026
Circulating levels of insulin-like growth factor binding protein 7 are associated with risks of chronic diseases and death

Li Z., Tao C., Zhou Z. et al.

Olink Explore 3072/384AgingPathophysiologyPlasma

JACC: Basic to Translational Science, 2026
Mendelian Randomization Reveals Interleukin-6 Receptor-Lipoprotein(a) Interplay With Independent Cardiovascular Risk Reductions

Kheirkhah A., Di Maio S., Coassin S. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

Journal of Thrombosis and Haemostasis, 2026
ADAMTS13 and von Willebrand Factor in relation to vascular cognitive impairment and cerebral small vessel disease: the heart-brain connection study

Pomp A., Rosbergen M., de Maat M. et al.

Olink Target 96NeurologyNeurovascular DiseasesPathophysiologySerum

European Journal of Endocrinology, 2026
Plasma proteomic profiling identifies apolipoprotein A4 as a downregulated biomarker of adrenocortical carcinoma: a multi-platform discovery and validation study

Park S., Seo H., Moon S. et al.

Olink Explore 3072/384OncologyPatient StratificationCross-platform ValidationPlasma

American Journal of Respiratory and Critical Care Medicine, 2026
Circulating Biomarker Results From a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension

Osterhout R., Boucly A., Benza R. et al.

Olink Explore 3072/384CVDPathophysiologyPlasma

4520 publications